Working with TipRanks
Follow Us
Stock Ideas
Daily Updates
Calendars
Education
About Us
Working with TipRanks
Follow Us
uniQure N.V. (GB:0EE0)
LSE:0EE0
uniQure (0EE0) Share Price & Analysis
0 Followers
0EE0 Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$13.28 - $27.78
Previous Close$19.21
Volume48.00
Average Volume (3M)505.00
Market Cap
$954.06M
Enterprise Value$942.20M
Total Cash (Recent Filing)$153.85M
Total Debt (Recent Filing)$142.00M
Price to Earnings (P/E)N/A
Beta0.63
Next Earnings
Aug 02, 2023EPS Estimate
$1.15Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding47,580,000
10 Day Avg. Volume215
30 Day Avg. Volume505
Standard Deviation0.23
R-Squared0.09
Alpha0.03
Financial Highlights & Ratios
Price to Book (P/B)2.81
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-2.90
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue9.00
Enterprise Value/Gross Profit-281.84
Enterprise Value/Ebitda-6.74
Forecast
1Y Price Target
$54.93Price Target Upside185.94% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering9
uniQure News
0EE0 FAQ
What was uniQure N.V.’s price range in the past 12 months?
uniQure N.V. lowest share price was $13.28 and its highest was $27.78 in the past 12 months.
What is uniQure N.V.’s market cap?
Currently, no data Available
When is uniQure N.V.’s upcoming earnings report date?
uniQure N.V.’s upcoming earnings report date is Aug 02, 2023 which is in 58 days.
How were uniQure N.V.’s earnings last quarter?
uniQure N.V. released its earnings results on May 09, 2023. The company reported -$1.63 earnings per share for the quarter, missing the consensus estimate of -$0.947 by -$0.683.
Is uniQure N.V. overvalued?
According to Wall Street analysts uniQure N.V.’s price is currently Undervalued.
Does uniQure N.V. pay dividends?
uniQure N.V. does not currently pay dividends.
What is uniQure N.V.’s EPS estimate?
uniQure N.V.’s EPS estimate is $1.15.
How many shares outstanding does uniQure N.V. have?
Currently, no data Available
What happened to uniQure N.V.’s price movement after its last earnings report?
uniQure N.V. reported an EPS of -$1.63 in its last earnings report, missing expectations of -$0.947. Following the earnings report the stock price went up 0.713%.
Which hedge fund is a major shareholder of uniQure N.V.?
Among the largest hedge funds holding uniQure N.V.’s share is Woodline Partners LP. It holds uniQure N.V.’s shares valued at 3M.
---
uniQure Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$54.93 (185.94% Upside)
$54.93 (185.94% Upside)
Blogger Sentiment
Bullish
GB:0EE0 Sentiment 100%
Sector Average 71%
Sector Average 71%
Insider Transactions
Sold Shares
Worth $1.3M over
the Last 3 Months
the Last 3 Months
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
36.67%
12-Months-Change
Fundamentals
Return on Equity
-32.82%
Trailing 12-Months
Asset Growth
-16.66%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
uniQure N.V.
uniQure NV engages in the research, development, and commercialization of gene therapies. Its discoveries intend to treat hemophilia, Huntington's disease, glybera, and cardiovascular problems. The company was founded by Sander J. van Deventer in 1998 and is headquartered in Amsterdam, the Netherlands.
---
uniQure
―
Abeona Therapeutics
―
Adverum Biotechnologies
―
Bellicum Pharmaceuticals
―
Crispr Therapeutics AG
―
---